Prognostic Value of C-Reactive Protein–Albumin–Lymphocyte (CALLY) Index for Survival in Nivolumab-Treated Metastatic Renal Cell Carcinoma

<i>Background and Objectives</i>: Metastatic renal cell carcinoma (mRCC) remains a lethal disease despite advances with immune checkpoint inhibitors such as nivolumab. However, a substantial proportion of patients exhibit primary resistance or early progression, highlighting the need for reliable an...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Ali Fuat Gürbüz, Mehmet Zahid Koçak, Oğuzhan Yıldız, Ömer Genç, Bahattin Engin Kaya, Talat Aykut, Melek Karakurt Eryılmaz, Murat Araz, Mehmet Artaç
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2026-05-01
Serija:	Medicina
Teme:	CALLY index renal cell carcinoma nivolumab immunotherapy prognostic biomarker
Online dostop:	https://www.mdpi.com/1648-9144/62/6/1009
Oznake:	Označite Brez oznak, prvi označite!